AI Spine Surgery Firm Carlsmed Shares Fall 6.7% After IPO
Shares in the firm traded at $14 each on Wednesday as of 12:04 p.m. in New York, versus the IPO price of $15 apiece. Carlsmed, which uses AI to personalize spine surgery, sold 6.7 million shares after offering them for $14 to $16 each.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Bloomberg
a minute ago
- Bloomberg
Congo Peace May Herald $700 Million Power Deal With US Company
Symbion Power LLC is proposing a 140-megawatt power plant and transmission lines along the border of Democratic Republic of Congo and Rwanda if the two countries can implement a recent US-backed peace agreement. The New York-based firm pitched to spend $700 million on converting methane gas to electricity on the Congolese side of Lake Kivu in the context of an economic integration deal signed between the two nations, according to Symbion and US officials. The company already planned a smaller plant on the lake, but development was stalled by conflict in the region.
Forbes
a minute ago
- Forbes
Striking The Right Balance: AI, Humans And The Go-To-Market Engine
Aaron Biggs, VP of Revenue at Summit, is a tenured technology leader with expertise in growth, go-to-market strategy and customer success. If you're a sales or marketing leader right now, there's a good chance you're feeling the squeeze: Every budget conversation includes some variant of "Why haven't we automated this yet?" or "Can't we just add an AI tool instead of hiring?" It's a fair question. AI has been positioned as the great equalizer, offering scale, speed and analytics that no human could match. But when it comes to your go-to-market (GTM) motion, the right answer isn't binary. It's not a matter of AI or people. It's about deploying the right blend of automation and human engagement to differentiate in an increasingly impersonal landscape. The AI Temptation (And The Risk) AI is a powerful accelerant. Sales enablement, lead scoring, content generation, personalization at scale—these are all fertile ground for AI-driven efficiencies. But here's the rub: Automation alone can only get you to parity with competitors also wielding AI. Where AI starts to struggle is where the complexity of human decision making and the nuances of buyer behavior live. AI can help you predict when to reach out, but it can't (yet) sit across from a client, read the room and navigate the layered politics within an account. As of now, there's no GPT model that can decode why a champion suddenly went cold because of an internal reorg. At Summit, we often see clients eager to deploy AI tools for their infrastructure, sales or customer support, hoping for an overnight transformation. Yet the most successful outcomes come when those tools are implemented alongside strategies that amplify human expertise, not bypass it. Over-indexing on AI tooling risks creating a sterile buyer journey, efficient but undifferentiated. And in a market where experience is the differentiator, that's a strategic misstep. Human-Driven, AI-Augmented GTM What high-performing organizations are discovering is that AI is best used to augment the human component of sales and marketing, not replace it. • Insight Generation: AI can synthesize vast data sets, surfacing insights that enable sales teams to be more strategic in account planning. • Administrative Automation: Free your best sellers from data entry and research tasks, empowering them to do what they do best: Build relationships and navigate complex deals. • Content And Messaging Support: AI can help draft messaging frameworks, but humans still need to tailor the message to the specific business context, industry trends and stakeholder personas. When you approach AI as a co-pilot rather than an autopilot, you empower your teams to deliver a buyer experience that feels both personalized and thoughtful with the added speed and intelligence that AI brings. At Summit, we embrace this philosophy ourselves. Whether we're designing cloud infrastructure solutions, managed services or data protection strategies, we integrate automation and AI insights where they add value, but we always keep a seasoned expert in the loop to guide the client through complex decisions. It's how we ensure every engagement feels custom-fit, not cookie-cutter. The Buyer Experience Is Your Differentiator Buyers today are sophisticated. They know when they're talking to a bot, and they're increasingly resistant to cookie-cutter outreach. The buyer experience itself has become a competitive advantage, especially in complex B2B deals where relationships and trust still matter. Human sellers backed by AI insights can better read the subtle signals of buying intent, customize their engagement strategy and build the credibility that moves deals forward. This is especially critical in late-stage sales conversations and renewals—areas where trust and authenticity outweigh automation. At Summit, we see this play out in the infrastructure space all the time. Customers evaluating cloud hosting, colocation or disaster recovery solutions aren't just buying capacity, they're buying confidence. They want a partner who understands their business, anticipates risks and tailors solutions to their unique needs. AI helps us identify patterns and flag potential issues early, but it's our people who bring the consultative insight that wins trust. How To Invest Smartly When debating whether to invest in more AI tools or expand your GTM team, ask yourself: 1. Where are our current bottlenecks? If reps are buried in admin work, automation can free them up. If you lack deep account penetration, consider expanding human resources. 2. Where is the buyer journey breaking down? AI can improve early-stage lead gen and qualification, but mid-to-late funnel stages often benefit more from experienced human engagement. 3. What is our differentiation strategy? If experience, service and expertise are how you win, human investment should be prioritized and AI should act as a support layer. 4. How will we continuously optimize? The best AI tools improve with data and feedback, but your people are the ones providing that feedback loop. Summit routinely reviews the performance of our AI-driven insights with our client-facing teams to ensure we're tuning our approach, not just scaling it. A Practical Example From The Field In our own GTM efforts at Summit, we've invested in AI to streamline prospect research, competitive analysis and even content recommendations tailored for vertical markets like financial services or SaaS providers. But we also bolstered our sales engineering team to ensure that when a prospect raises a technical question, there's a real expert who can engage in depth. That combination of AI-enhanced targeting paired with human expertise has helped us build credibility faster and progress conversations more effectively than if we had leaned exclusively on automation or hiring alone. Final Thought AI isn't here to replace your people; it's here to make them more effective. But leaders need to resist the allure of full automation at the cost of buyer experience. The organizations that win in this new era will be those who get the blend right, pairing human authenticity with AI-powered intelligence to meet buyers where they are, with what they truly need. Summit's own journey has taught us that the future isn't AI versus humans. It's AI with humans. And when you strike that balance? You won't just keep up. You'll lead. Forbes Business Development Council is an invitation-only community for sales and biz dev executives. Do I qualify?
Yahoo
25 minutes ago
- Yahoo
NHC Reports Second Quarter 2025 Earnings
MURFREESBORO, Tenn., August 08, 2025--(BUSINESS WIRE)--National HealthCare Corporation (NYSE American: NHC), the nation's oldest publicly traded senior health care company, announced today net operating revenues for the quarter ended June 30, 2025 totaled $374,910,000 compared to $300,658,000 for the quarter ended June 30, 2024, an increase of 24.7%. The increase in net operating revenues for the second quarter of 2025 compared to the second quarter of 2024 was due to an 9.6% increase in same-facility net operating revenues, as well as the August 1, 2024 acquisition of White Oak Management, Inc. ("White Oak"). For the quarter ended June 30, 2025, the reported GAAP net income attributable to NHC was $23,722,000 compared to $26,844,000 for the same period in 2024. Excluding the unrealized gains and losses in our marketable equity securities portfolio and other non-GAAP adjustments, adjusted net income for the quarter ended June 30, 2025 was $25,710,000 compared to $15,612,000 for the same period in 2024, an increase of 64.7% (*). The GAAP diluted earnings per share were $1.52 and $1.73 for the quarters ending June 30, 2025 and 2024, respectively. Adjusted diluted earnings per share were $1.65 and $1.00 for the quarters ending June 30, 2025 and 2024, respectively (*). (*) - See the tables below that provide a reconciliation of GAAP to non-GAAP items. About NHCAs of August 1, 2025, NHC affiliates operate for themselves and third parties 80 skilled nursing facilities with 10,329 beds. NHC affiliates also operate 26 assisted living communities with 1,413 units, nine independent living communities with 777 units, three behavioral health hospitals, 34 homecare agencies, and 33 hospice agencies. NHC's other services include Alzheimer's and memory care units, pharmacy services, a rehabilitation services company, and providing management and accounting services to third party post-acute operators. Other information about the company can be found on our web site at Non-GAAP Financial PresentationThe Company is providing certain non-GAAP financial measures as the Company believes that these figures are helpful in allowing investors to more accurately assess the ongoing nature of the Company's operations and measure the Company's performance more consistently across periods. Therefore, the Company believes this information is meaningful in addition to the information contained in the GAAP presentation of financial information. The presentation of this additional non-GAAP financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP. Forward-Looking StatementsStatements in this press release that are not historical facts are forward-looking statements. NHC cautions investors that any forward-looking statements made involve risks and uncertainties and are not guarantees of future performance. The risks and uncertainties are detailed from time to time in reports filed by NHC with the S.E.C., including Forms 8-K, 10-Q, and 10-K. All forward-looking statements represent NHC's best judgment as of the date of this release. Consolidated Statements of Operations (in thousands, except share and per share amounts) Three Months Ended Six Months Ended June 30 June 30 2025 2024 2025 2024 (unaudited) (unaudited) Revenues: Net patient revenues $ 363,349 $ 279,918 $ 724,956 $ 565,741 Other revenues 11,561 11,295 23,651 22,648 Government stimulus income - 9,445 - 9,445 Net operating revenues and grant income 374,910 300,658 748,607 597,834 Costs and expenses: Salaries, wages and benefits 226,534 180,076 454,664 363,214 Other operating 91,943 78,154 184,400 155,583 Facility rent 11,328 10,570 22,693 20,918 Depreciation and amortization 11,015 9,338 21,993 19,924 Total costs and expenses 340,820 278,138 683,750 559,639 Income from operations 34,090 22,520 64,857 38,195 Non-operating income 5,132 4,956 9,211 10,641 Interest expense (1,993 ) - (4,099 ) (46 ) Unrealized gains/(losses) on marketable equity securities (5,061 ) 9,124 5,921 23,523 Income before income taxes 32,168 36,600 75,890 72,313 Income tax provision (8,055 ) (9,494 ) (19,487 ) (18,956 ) Net income 24,113 27,106 56,403 53,357 Net income attributable to noncontrolling interest (391 ) (262 ) (476 ) (300 ) Net income attributable to National HealthCare Corporation $ 23,722 $ 26,844 $ 55,927 $ 53,057 Net income per common share Basic $ 1.53 $ 1.74 $ 3.62 $ 3.45 Diluted $ 1.52 $ 1.73 $ 3.59 $ 3.42 Weighted average common shares outstanding Basic 15,462,135 15,391,535 15,450,286 15,371,150 Diluted 15,599,638 15,555,612 15,587,783 15,530,624 Dividends declared per common share $ 0.64 $ 0.61 $ 1.25 $ 1.20 Balance Sheet Data June 30 December 31 (in thousands) 2025 2024 (unaudited) Cash, cash equivalents and marketable securities $ 257,628 $ 216,185 Restricted cash, cash equivalents and marketable securities 169,340 163,795 Current assets 463,227 424,408 Property and equipment, net 676,619 684,289 Total assets 1,562,220 1,524,429 Current liabilities, excluding current long-term debt 261,245 227,297 Current and long-term debt 110,000 137,000 NHC stockholders' equity 1,021,905 980,161 Selected Operating Statistics Three Months Ended Six Months Ended June 30 June 30 2025 2024 2025 2024 (unaudited) (unaudited) Skilled Nursing Per Diems: Medicare $ 614.85 $ 577.71 $ 613.47 $ 579.81 Managed Care 486.17 447.96 489.30 459.48 Medicaid 286.43 264.49 284.07 264.88 Private Pay and Other 341.34 312.91 339.24 310.31 Average Skilled Nursing Per Diem $ 361.42 $ 338.86 $ 360.78 (1) $ 341.21 (1) Skilled Nursing Patient Days: Medicare 83,615 74,602 169,869 155,758 Managed Care 83,015 62,957 166,661 128,388 Medicaid 368,687 279,504 732,329 561,325 Private Pay and Other 194,202 150,234 378,796 307,677 Total Skilled Nursing Patient Days 729,519 567,297 1,447,655 (1) 1,153,148 (1) (1) NHC exited three skilled nursing facilities in Missouri on March 1, 2024. For the six months ended June 30, 2024, the exited Missouri skilled nursing facilities had an average skilled nursing per diem of $275.64 and 20,267 patient days. The tables below provide reconciliations of GAAP to non-GAAP items (in thousands, except per share amounts): Three Months Ended Six Months Ended June 30 June 30 2025 2024 2025 2024 (unaudited) (unaudited) Net income attributable to National Healthcare Corporation $ 23,722 $ 26,844 $ 55,927 $ 53,057 Non-GAAP adjustments Unrealized (gains)/losses on marketable equity securities 5,061 (9,124 ) (5,921 ) (23,523 ) Operating losses for newly-opened operations not at full capacity - 20 - 20 Gain on sale of property and equipment (3,606 ) - (3,606 ) - Gain on sale of unconsolidated company - - - (1,024 ) Stock-based compensation expense 1,232 1,176 2,260 1,969 Acquisition-related expenses - 2,194 - 2,194 Employee retention credit - (9,445 ) - (9,445 ) Income tax provision/(benefit) on non-GAAP adjustments (699 ) 3,947 1,889 7,750 Non-GAAP Net income $ 25,710 $ 15,612 $ 50,549 $ 30,998 GAAP diluted earnings per share $ 1.52 $ 1.73 $ 3.59 $ 3.42 Non-GAAP adjustments Unrealized (gains)/losses on marketable equity securities 0.32 (0.59 ) (0.38 ) (1.51 ) Gain on sale of property and equipment (0.23 ) - (0.23 ) - Gain on sale of unconsolidated company - - - (0.07 ) Stock-based compensation expense 0.08 0.08 0.14 0.13 Acquisition-related expenses - 0.14 - 0.14 Employee retention credit - (0.61 ) - (0.61 ) Income tax provision/(benefit) on non-GAAP adjustments (0.04 ) 0.25 0.12 0.50 Non-GAAP diluted earnings per share $ 1.65 $ 1.00 $ 3.24 $ 2.00 View source version on Contacts Brian F. Kidd, SVP/CFOPhone: (615) 890-2020
